Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
- Conditions
- Congenital DislocationsHip ReplacementPrimary, Secondary or Post-traumatic OsteoarthrosisFemur Head NecrosisPrimary and Revision Surgery
- Registration Number
- NCT02230826
- Lead Sponsor
- Corin
- Brief Summary
This long-term outcomes study is designed to collect safety and efficacy data on designated, commercially available, hip arthroplasty products.
- Detailed Description
Outcome data collected from this study will be used for Post Market Surveillance (PMS) and Clinical Evaluations on Corin hip devices and will support peer-reviewed publications on products performance and safety at long term follow-up.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 2500
- Man or woman >18 years
- Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study
- Subjects who agreed for study participation.
- Subjects with existing tumour and/or particularly high surgical risk-
- Subjects with anaesthetic risk class IV or higher
- Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.)
- Contraindications for arthroplasty with a Corin hip devices as per product IFU
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of long-term outcome after hip arthroplasty with Corin implants. At 10 years Implants revision rate at 10-year FU hip arthroplasty
- Secondary Outcome Measures
Name Time Method Evaluation of long-term outcome after hip arthroplasty with Corin implants at 15 and 20-year FU. at 15- and 20-year Implants revision rate at 15- and 20-year FU.
Evaluation of patient quality of life starting intraoperatively up to 20-year FU Improvement of quality of life via EQ-5D-5L scores.
Evaluation of patient satisfaction following surgery 3 months ; 2.5-year; 6, 11, 15, 20-year visits Improvement of patient's satisfaction
Radiological evaluation of positioning and osteointegration of Corin hip implants. starting intraoperatively up to 20-year FU Number, thickness and location of radiolucent lines, osteolysis and heterotopic ossifications reported via radiological evaluation
Evaluation of clinical performance of Corin hip implants starting intraoperatively up to 20-year FU Change of Patient Reported Outcome Measures (PROMs)
Evaluation of Safety of Corin hip implants starting intraoperatively up to 20-year FU Number, severity and causal relationship of procedure or implant-related Adverse Events
Trial Locations
- Locations (13)
CHU de Bordeaux - Groupe Hospitalier Pellegrin
🇫🇷Bordeaux, France
clinique Oxford Cannes
🇫🇷Cannes, France
CH Dunkerque
🇫🇷Dunkerque, France
Polyclinique Henin Beaumont
🇫🇷Hénin-Beaumont, France
CHU de Nice
🇫🇷Nice, France
Centre Hospitalier Régionnal d'Orléans - Site La Source
🇫🇷Orléans, France
Clinique Arago
🇫🇷Paris, France
Hôpital de la Croix Saint-Simon
🇫🇷Paris, France
Hopital privé Saint-Martin
🇫🇷Pessac, France
Hôpital Provo
🇫🇷Roubaix, France
Polyclinique St Georges de Didonne
🇫🇷St Georges de Didonne, France
Médipôle Garonne
🇫🇷Toulouse, France
Hôpital Jean Bernard
🇫🇷Valenciennes, France